Skip to content

Clinical Study on Tiaogeng Prescription Intervention in Early Menopausal Women with aMCI

Clinical Study on Tiaogeng Prescription Intervention in Early Menopausal Women with aMCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036772
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aMCI

Interventions

Sponsors

Longhua Hospital, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) 40~60 years old (including 60 years old); (2) Meet the diagnostic criteria of western medicine for menopausal syndrome and MCI; (3) Patients with deficiency of kidney yin and deficiency of both kidney yin and yang that meet the TCM syndrome differentiation standards; (4) 1 year <menopausal time < 9.5 years; (5) Those who voluntarily participated in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, liver, kidney, brain and other organic diseases and severe physical diseases and malignant tumors; (2) Patients with active thyroid disease; (3) Those who are allergic to known pharmaceutical ingredients; (4) Patients with severe depression (Beck Depression Inventory BDI-II score> 28 points); (5) Exclude people with cognitive dysfunction caused by trauma, brain tumors and surgery; (6) Alcohol and drug abusers; (7) Patients who have used banned drugs in the past 3 months or participated in other clinical trials; (8) Patients with folic acid and vitamin B12 deficiency.

Design outcomes

Primary

MeasureTime frame
Wechsler Memory Scale;Auditory Vocabulary Learning Test Huashan Version;MoCA Scale;

Secondary

MeasureTime frame
Evaluation of menopausal symptoms;Sleep quality assessment;TCM symptom assessment;Metabolic index evaluation;Serum sex hormone assessment;

Countries

China

Contacts

Public ContactLianwei Xu

Longhua Hospital,Shanghai University of Traditional Chinese Medicine

doctorsherryxlw@163.com+86 18917763165

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026